Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner.

× No keyword cloud information.

56 in total

1. Paradoxical Expansion of Th1 and Th17 Lymphocytes in Rheumatoid Arthritis Following Infliximab Treatment: a Possible Explanation for a Lack of Clinical Response.

Authors: Rossella Talotta; Angela Berzi; Fabiola Atzeni; Alberto Batticciotto; Mario Clerici; Piercarlo Sarzi-Puttini; Daria Trabattoni
Journal: J Clin Immunol Date: 2015-08-14 Impact factor: 8.317

Review 2. Immunogenicity of biologic agents in rheumatology.

Authors: Vibeke Strand; Joao Goncalves; John D Isaacs
Journal: Nat Rev Rheumatol Date: 2020-12-14 Impact factor: 20.543

Review 3. Immunogenicity of Biologic and Biosimilar Therapies for Psoriasis and Impact of Novel Immunoassays for Immunogenicity Detection.

Authors: Courtney E Heron; Rima I Ghamrawi; Esther A Balogh; Steven R Feldman
Journal: Am J Clin Dermatol Date: 2020-11-09 Impact factor: 7.403

4. Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis.

Authors: José Miguel Senabre Gallego; Jose Rosas; Mariana Marco-Mingot; José Alberto García-Gómez; Gregorio Santos-Soler; Esteban Salas-Heredia; Ana Pons-Bas; Xavier Barber-Vallés; José Antonio Bernal-Vidal; Catalina Cano-Pérez; Mario García-Carrasco; Emilio Flores-Pardo
Journal: Rheumatol Int Date: 2019-03-21 Impact factor: 2.631

5. [Uveitis in juvenile idiopathic arthritis].

Authors: I Foeldvari; K Walscheid; A Heiligenhaus
Journal: Z Rheumatol Date: 2017-10 Impact factor: 1.372

6. Approach to Optimize Anti-TNF-α Therapy in Patients With IBD.

Authors: Yuga Komaki; Fukiko Komaki; Atsushi Sakuraba; Russell Cohen
Journal: Curr Treat Options Gastroenterol Date: 2016-03

7. Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFα biologics in rheumatic diseases.

Authors: C C Mok; D van der Kleij; G J Wolbink
Journal: Clin Rheumatol Date: 2013-07-26 Impact factor: 2.980

8. Investigation of the Mechanism of Therapeutic Protein-Drug Interaction Between Methotrexate and Golimumab, an Anti-TNFα Monoclonal Antibody.

Authors: Weirong Wang; Jocelyn Leu; Rebecca Watson; Zhenhua Xu; Honghui Zhou
Journal: AAPS J Date: 2018-04-17 Impact factor: 4.009

9. Use of Immunosuppressive Medications for Treatment of Pediatric Intermediate Uveitis.

Authors: Aimee O Hersh; Spencer Cope; John F Bohnsack; Akbar Shakoor; Albert T Vitale
Journal: Ocul Immunol Inflamm Date: 2016-12-14 Impact factor: 3.070

Review 10. Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges.

Authors: Emilie M J van Brummelen; Willeke Ros; Gertjan Wolbink; Jos H Beijnen; Jan H M Schellens
Journal: Oncologist Date: 2016-07-20